Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Analyst Comments: Anadys Pharma, HealthSouth, Tractor Supply, State Auto Financial, ICICI Bank
Aug 01, 2008 12:33 PM
- Analyst Comments: Ciena Corp., Anadys, Coca-Cola, Jabil Circuit, Vertex Pharma, CRA International, Ferrellgas, Soapstone
Jun 06, 2008 04:24 PM
- Published Third Party, Independent Research Corroborates Promise of TAP Cancer Therapeutic as a Therapy for the Treatment of Cancer and Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
Jun 03, 2008 09:29 AM
- Analyst Comments: AMERCO, Baker Hughes, LoopNet, Grey Wolf, Anadys Pharmaceuticals, Kyocera, Varco, Alvarion, Alexion
May 02, 2008 10:12 AM
- Rhyme Nor Reason
Feb 21, 2008 09:28 AM
- Jobs Report
Jan 04, 2008 10:29 AM
- Analyst Comments: Borg Warner, Vimpel-Communications, Anadys Pharmaceuticals, Procter & Gamble, UDR Inc
Jan 03, 2008 10:36 AM
- Profitability a Ways Off for ANDS
Sep 27, 2007 06:29 PM
- ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
Dec 01, 2008 06:38 PM
- Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
Nov 25, 2008 06:31 PM
- Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
Nov 13, 2008 05:51 PM
- Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
Nov 04, 2008 04:05 PM
- Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
Nov 01, 2008 10:01 AM
- Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
Oct 30, 2008 04:06 PM
- Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
Oct 28, 2008 04:53 PM
- Anadys Pharmaceuticals to Present at Bio Investor Forum
Oct 27, 2008 06:37 PM
- Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
Oct 23, 2008 04:33 PM
- Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
Oct 20, 2008 06:33 PM
- Form 4 SCANGOS GEORGE A For: Aug 26 (10K)
Aug 28, 2008 02:53 PM
- Form 4 ANADYS PHARMACEUTICALS For: Aug 05 Filed by: Freddo James L (10K)
Aug 06, 2008 01:18 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: WORLAND STEPHEN T (10K)
May 30, 2008 08:59 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: XANTHOPOULOS KLEANTHIS G (10K)
May 30, 2008 08:56 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: WILLIAMS DOUGLAS E (10K)
May 30, 2008 08:54 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: SCANGOS GEORGE A (10K)
May 30, 2008 08:52 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: PAPADOPOULOS STELIOS (10K)
May 30, 2008 08:49 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: Holtzman Steven H (10K)
May 30, 2008 08:47 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: FOTIADIS MARIOS (10K)
May 30, 2008 08:44 PM
- Form 4 ANADYS PHARMACEUTICALS For: May 30 Filed by: FOLETTA MARK G (10K)
May 30, 2008 08:41 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
ANDS
|
Compare to S&P
|
| YTD |
22.36 %
|
100.47 %
|
| 4 Weeks |
-10.45 %
|
-3.21 %
|
| 12 Weeks |
-29.14 %
|
-1.77 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -28.00 %
|
|
EPS Growth in Last Year: -174.42 %
|
|
Sales Growth in Last Quarter: -98.95 %
|
|
Sales Growth in Last Quarter: -80.45 %
|
|
|
